United StatesInsights

Grafa

Nike margin rebound puts footwear rivals on notice

  • Nike reported Q4 fiscal 2026 revenue of $11 billion, down 1% on a reported basis and down 4% on a currency-neutral basis.
  • Gross margin rose 890 basis points to 49.2%, mainly due to an approximately 900 basis point benefit tied to expected IEEPA tariff recovery.
  • The main sector issue is whether athletic brands can protect margins while wholesale demand, direct sales, tariffs, and cautious consumers reshape growth.
Read more
Grafa

Security software stocks face a fresh profit test

  • BlackBerry reported Q1 FY2027 revenue of $152.9 million, up 26% year over year, with adjusted EBITDA of $36.3 million and GAAP operating income of $15.3 million.
  • The comparison group shows a wide revenue gap, from Cerence’s $64.2 million quarterly revenue to Palo Alto Networks’ $3 billion quarterly revenue.
  • The main sector test is whether AI security, connected-vehicle software, and government communications can keep growing while margins stay under control.
Read more
Grafa

How escalating artificial intelligence hardware demand is rewriting memory chip valuations

  • Micron Technology reported $41.46 billion in quarterly revenue as the firm capitalized on surging data center component demand.
  • The semiconductor manufacturer recorded a GAAP net income of $28.24 billion and declared a quarterly dividend of $0.15 per share.
  • Global hardware manufacturers must carefully secure raw materials to execute aggressive revenue projections amid volatile enterprise capital expenditures.
Read more
Grafa

How global delivery networks are quietly sacrificing scale to protect operational margins

  • FedEx reported $25 billion in fourth-quarter fiscal 2026 revenue while executing a spin-off of its freight division to consolidate core operations.
  • The logistics provider exceeded cost-cutting targets by securing over $1 billion in structural savings and achieving an adjusted earnings per share of $6.60.
  • Global transportation firms face mounting pressure to offset mixed profitability trends by heavily reducing capital spending and divesting secondary business units.
Read more
Grafa

Why dominant pharmaceutical firms are paying billion-dollar premiums for immunology assets

  • AbbVie agreed to acquire Apogee Therapeutics in a $10.9 billion all-cash transaction, paying a 60% premium to secure a late-stage immunology pipeline.
  • The company will pay $135.11 per share, with executives projecting the deal will not become accretive to adjusted earnings until 2032.
  • Large pharmaceutical manufacturers face intense capital pressure to acquire unproven, long-acting biologics to offset impending revenue losses from patent expirations.
Read more
Grafa

WiseTech shares plunge amid federal fraud investigation

  • Federal authorities are investigating WiseTech Global (ASX:WTC) executive chairman Richard White over visa fraud and human trafficking allegations.
  • The ongoing controversy triggered a sharp market sell-off, pulling the WiseTech share price down to $36.88.
  • Institutional investors are reassessing sector governance and operational risk amid wider software industry headwinds.
Read more
Grafa

The hidden manufacturing race to build the physical backbone of AI

  • Jabil’s Q3 fiscal 2026 revenue reached $8.8 billion, with management signaling strong future demand for AI-native infrastructure and cooling systems.
  • The company reported U.S. GAAP operating income of $445 million and core diluted earnings per share of $3.16, as it pivots toward high-speed AI interconnects.
  • The broader sector faces a structural shift as contract manufacturers race to expand domestic capacity for power-intensive, liquid-cooled data center hardware.
Read more
Grafa

How artificial intelligence investments are quietly reshaping technology consulting valuations

  • Accenture reported $18.7 billion in quarterly revenue, yet its stock fell 13.3% to $143.50.
  • The firm recorded $19.3 billion in new bookings and expanded operating margins to 17%.
  • Consulting firms face mounting investor pressure to convert enterprise artificial intelligence demand into immediate profitability.
Read more

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.